동물용 바이오마커 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 동물 유형별, 제품 유형별, 용도별, 질환 유형별, 지역별, 경쟁별(2020-2030년)
Veterinary Biomarkers Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type, By Product Type, By Application, By Disease Type, By Region, & Competition, 2020-2030F
동물용 바이오마커 세계 시장 규모는 2024년 9억 6,553만 달러로 예측 기간 동안 12.30%의 CAGR로 2030년까지 괄목할 만한 성장이 예상됩니다.
동물용 바이오마커 세계 시장이란 동물용 헬스케어 산업에서 질병 진단, 동물의 건강 상태 모니터링, 동물의 치료 효과 평가에 바이오마커를 사용하는 분야를 말합니다. 바이오마커는 단백질, 유전자, 대사산물 등의 측정 가능한 지표로 동물의 다양한 생리적, 병리학적 과정을 감지하고 정량화하기 위해 사용됩니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
9억 6,553만 달러 |
| 시장 규모 : 2030년 |
19억 4,086만 달러 |
| CAGR : 2025-2030년 |
12.30% |
| 급성장 부문 |
반려동물 |
| 최대 시장 |
북미 |
시장 촉진요인
동물 질병 및 인수공통전염병의 유행 증가
주요 시장 과제
검증 및 표준화
주요 시장 동향
POC(Point-of-Care) 진단의 부상
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 동물용 바이오마커 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 동물 유형별(반려동물, 생산동물)
- 제품 유형별(바이오마커, 키트와 시약, 바이오마커 리더)
- 용도별(질환 진단, 전임상 연구, 기타)
- 질환 유형별(염증성 및 감염증, 심혈관질환, 골격근 질환, 종양, 기타)
- 지역별
- 기업별(2024년)
- 제품 시장 맵
- 동물 유형별
- 제품 유형별
- 용도별
- 질환 유형별
- 지역별
제6장 북미의 동물용 바이오마커 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 동물용 바이오마커 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 동물용 바이오마커 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 동물용 바이오마커 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 동물용 바이오마커 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
제11장 시장 역학
제12장 시장 동향과 발전
제13장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 능력
- 고객의 능력
- 대체품의 위협
제14장 경쟁 구도
- Zoetis Inc.
- Virbac SA
- Life Diagnostics Inc
- Acuvet Biotech
- Merck & Co., Inc.
- IDEXX Laboratories, Inc.
- Mercodia AB
- Antech Diagnostics Inc
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
Global Veterinary Biomarkers Market was valued at USD 965.53 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.30% through 2030. The Global Veterinary Biomarkers Market refers to the sector within the veterinary healthcare industry that deals with the use of biomarkers for diagnosing diseases, monitoring animal health, and assessing treatment efficacy in animals. Biomarkers are measurable indicators, such as proteins, genes, or metabolites, that can be used to detect and quantify various physiological and pathological processes in animals.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 965.53 Million |
| Market Size 2030 | USD 1940.86 Million |
| CAGR 2025-2030 | 12.30% |
| Fastest Growing Segment | Companion Animals |
| Largest Market | North America |
Key Market Drivers
Rising Prevalence of Animal Diseases and Zoonotic Infections
The rising prevalence of animal diseases and zoonotic infections is a critical factor driving the growth of the Global Medical Scheduling Software Market. Globally, zoonotic diseases account for approximately one billion illness cases and millions of fatalities annually. Zoonoses comprise 60% of all newly emerging infectious diseases, underscoring their significant public health impact. Over the past 30 years, more than 30 novel human pathogens have been identified, with 75% originating from animals, highlighting the critical need for enhanced disease surveillance, veterinary healthcare advancements, and cross-sectoral collaboration to mitigate the risks of animal-to-human transmission. As veterinary clinics, hospitals, research centers, and government agencies strive to manage the increasing burden of infectious and chronic diseases in animals, the demand for efficient appointment scheduling, resource allocation, and workflow optimization is escalating. Below is an in-depth analysis of how the growing incidence of animal-related diseases is fueling the expansion of medical scheduling software in the veterinary and broader healthcare sectors.
Key Market Challenges
Validation and Standardization
Validating and standardizing biomarker assays for veterinary use is essential for ensuring accuracy and reliability. Establishing consistent standards and methodologies is challenging due to the diversity of animal species, breeds, and health conditions. This lack of standardization can hinder the widespread adoption of biomarker-based diagnostics and treatments.
Key Market Trends
Rise of Point-of-Care Diagnostics
Point-of-care diagnostics are revolutionizing veterinary medicine by providing rapid and on-site testing capabilities. These portable and user-friendly devices allow veterinarians to perform biomarker-based tests right in the clinic, enabling quicker diagnoses and immediate treatment decisions. The convenience of point-of-care testing is expected to drive its adoption in veterinary practices.
Key Market Players
- Zoetis Inc.
- Virbac SA
- Life Diagnostics Inc
- Acuvet Biotech
- Merck & Co., Inc.
- IDEXX Laboratories, Inc.
- Mercodia AB
- Antech Diagnostics Inc
Report Scope:
In this report, the Global Veterinary Biomarkers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Veterinary Biomarkers Market, By Animal Type:
- Companion Animals
- Production Animals
Veterinary Biomarkers Market, By Product Type:
- Biomarkers
- Kits & Reagents
- Biomarker Readers
Veterinary Biomarkers Market, By Application:
- Disease Diagnostics
- Preclinical Research
- Others
Veterinary Biomarkers Market, By Disease Type:
- Inflammatory & Infectious Diseases
- Cardiovascular Diseases
- Skeletal Muscle Diseases
- Tumor
- Others
Veterinary Biomarkers Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Biomarkers Market.
Available Customizations:
Global Veterinary Biomarkers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Veterinary Biomarkers Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Animal Type (Companion Animals, Production Animals)
- 5.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
- 5.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
- 5.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
- 5.3. Product Market Map
- 5.3.1. By Animal Type
- 5.3.2. By Product Type
- 5.3.3. By Application
- 5.3.4. By Disease Type
- 5.3.5. By Region
6. North America Veterinary Biomarkers Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
- 6.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
- 6.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
- 6.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Veterinary Biomarkers Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Animal Type
- 6.3.1.2.2. By Product Type
- 6.3.1.2.3. By Application
- 6.3.1.2.4. By Disease Type
- 6.3.2. Canada Veterinary Biomarkers Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Animal Type
- 6.3.2.2.2. By Product Type
- 6.3.2.2.3. By Application
- 6.3.2.2.4. By Disease Type
- 6.3.3. Mexico Veterinary Biomarkers Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Animal Type
- 6.3.3.2.2. By Product Type
- 6.3.3.2.3. By Application
- 6.3.3.2.4. By Disease Type
7. Europe Veterinary Biomarkers Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
- 7.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
- 7.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
- 7.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Veterinary Biomarkers Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Animal Type
- 7.3.1.2.2. By Product Type
- 7.3.1.2.3. By Application
- 7.3.1.2.4. By Disease Type
- 7.3.2. United Kingdom Veterinary Biomarkers Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Animal Type
- 7.3.2.2.2. By Product Type
- 7.3.2.2.3. By Application
- 7.3.2.2.4. By Disease Type
- 7.3.3. France Veterinary Biomarkers Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Animal Type
- 7.3.3.2.2. By Product Type
- 7.3.3.2.3. By Application
- 7.3.3.2.4. By Disease Type
- 7.3.4. Italy Veterinary Biomarkers Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Animal Type
- 7.3.4.2.2. By Product Type
- 7.3.4.2.3. By Application
- 7.3.4.2.4. By Disease Type
- 7.3.5. Spain Veterinary Biomarkers Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Animal Type
- 7.3.5.2.2. By Product Type
- 7.3.5.2.3. By Application
- 7.3.5.2.4. By Disease Type
8. Asia-Pacific Veterinary Biomarkers Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
- 8.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
- 8.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
- 8.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
- 8.2.5. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Veterinary Biomarkers Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Animal Type
- 8.3.1.2.2. By Product Type
- 8.3.1.2.3. By Application
- 8.3.1.2.4. By Disease Type
- 8.3.2. Japan Veterinary Biomarkers Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Animal Type
- 8.3.2.2.2. By Product Type
- 8.3.2.2.3. By Application
- 8.3.2.2.4. By Disease Type
- 8.3.3. India Veterinary Biomarkers Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Animal Type
- 8.3.3.2.2. By Product Type
- 8.3.3.2.3. By Application
- 8.3.3.2.4. By Disease Type
- 8.3.4. Australia Veterinary Biomarkers Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Animal Type
- 8.3.4.2.2. By Product Type
- 8.3.4.2.3. By Application
- 8.3.4.2.4. By Disease Type
- 8.3.5. South Korea Veterinary Biomarkers Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Animal Type
- 8.3.5.2.2. By Product Type
- 8.3.5.2.3. By Application
- 8.3.5.2.4. By Disease Type
9. South America Veterinary Biomarkers Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
- 9.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
- 9.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
- 9.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
- 9.2.5. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Veterinary Biomarkers Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Animal Type
- 9.3.1.2.2. By Product Type
- 9.3.1.2.3. By Application
- 9.3.1.2.4. By Disease Type
- 9.3.2. Argentina Veterinary Biomarkers Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Animal Type
- 9.3.2.2.2. By Product Type
- 9.3.2.2.3. By Application
- 9.3.2.2.4. By Disease Type
- 9.3.3. Colombia Veterinary Biomarkers Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Animal Type
- 9.3.3.2.2. By Product Type
- 9.3.3.2.3. By Application
- 9.3.3.2.4. By Disease Type
10. Middle East and Africa Veterinary Biomarkers Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
- 10.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
- 10.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
- 10.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
- 10.2.5. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Veterinary Biomarkers Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Animal Type
- 10.3.1.2.2. By Product Type
- 10.3.1.2.3. By Application
- 10.3.1.2.4. By Disease Type
- 10.3.2. Saudi Arabia Veterinary Biomarkers Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Animal Type
- 10.3.2.2.2. By Product Type
- 10.3.2.2.3. By Application
- 10.3.2.2.4. By Disease Type
- 10.3.3. UAE Veterinary Biomarkers Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Animal Type
- 10.3.3.2.2. By Product Type
- 10.3.3.2.3. By Application
- 10.3.3.2.4. By Disease Type
- 10.3.4. Kuwait Veterinary Biomarkers Market Outlook
- 10.3.4.1. Market Size & Forecast
- 10.3.4.2. Market Share & Forecast
- 10.3.4.2.1. By Animal Type
- 10.3.4.2.2. By Product Type
- 10.3.4.2.3. By Application
- 10.3.4.2.4. By Disease Type
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
13. Porter's Five Forces Analysis
- 13.1. Competition in the Industry
- 13.2. Potential of New Entrants
- 13.3. Power of Suppliers
- 13.4. Power of Customers
- 13.5. Threat of Substitute Products
14. Competitive Landscape
- 14.1. Zoetis Inc.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
- 14.2. Virbac SA
- 14.3. Life Diagnostics Inc
- 14.4. Acuvet Biotech
- 14.5. Merck & Co., Inc.
- 14.6. IDEXX Laboratories, Inc.
- 14.7. Mercodia AB
- 14.8. Antech Diagnostics Inc
15. Strategic Recommendations
16. About Us & Disclaimer
